ASSESSMENT OF RISK FACTORS AND EARLY DIAGNOSIS OF ENDOMETRIAL HYPERPLASIA IN PERIMENOPAUSAL WOMEN

Authors

  • Guli I. Boltaeva
  • Malokhat F. Yakhshieva
  • Manzura K. Uzoqova

Keywords:

Endometrial hyperplasia, perimenopause, early detection

Abstract

Endometrial hyperplasia is an important problem of reproductive health of women in perimenopause, as hormonal changes characteristic of this period increase the risk of its development. The main risk factors are hormonal imbalance, obesity, diabetes, hypertension and hereditary predisposition. The most important diagnostic methods are ultrasound, hysteroscopy with biopsy and molecular genetic testing, which allows for timely detection of pathologies and prevention of their progression. Early detection and timely correction of hormonal levels, as well as prevention of obesity and control of chronic diseases are key measures for the prevention of endometrial hyperplasia and its complications, such as endometrial cancer.

References

Patel, S. M., & Chinnakali, P. (2020).

"Endometrial hyperplasia: Risk factors and

early diagnosis." Journal of Obstetrics and

Gynecology, 25(3), 45-56.

Kuhn, W., & He, Y. (2020). "Hormonal

therapy and endometrial hyperplasia in

postmenopausal women: A review."

Gynecological Endocrinology, 36(7), 543-

Wang, J., & Zhang, Y. (2019). "Obesity as

a risk factor for endometrial hyperplasia

and carcinoma." European Journal of

Obstetrics & Gynecology and Reproductive

Biology, 239, 40-45.4. Zhao, L., & Luo, X. (2021). "Molecular

mechanisms of endometrial hyperplasia

and cancer: An overview." Cancer Biology

& Therapy, 22(10), 1022-1030.

Sullivan, M. E., & Osborn, T. G. (2020).

"Clinical management of endometrial

hyperplasia in women of reproductive and

perimenopausal age." Journal of Women's

Health, 29(2), 208-214.

Schaefer, C., & Dreisler, E. (2018).

"Endometrial thickness measurement by

ultrasound: Diagnostic accuracy and

clinical relevance in detecting hyperplasia."

Ultrasound in Obstetrics & Gynecology,

(1), 30-35.

Kapp, D. S., & McLennan, J. M. (2021).

"The role of progesterone therapy in the

management of endometrial hyperplasia."

American Journal of Obstetrics and

Gynecology, 224(4), 485-493.

Carvalho, S. M., & Zamboni, A. (2022).

"Atypical endometrial hyperplasia and its

potential progression to endometrial

carcinoma." Oncology Reports, 47(1), 7-

Liu, Z., Zhang, Y., & Yang, M. (2019).

"The role of ultrasound in the diagnosis of

endometrial hyperplasia." Gynecological

Endocrinology, 34(1), 1-8.

Ng, L. M., & Tan, C. H. (2020).

"Endometrial biopsy and its role in

diagnosing endometrial hyperplasia: A

systematic review." Journal of Obstetrics

and Gynecology Research, 46(3), 542-548

Downloads

Published

2025-03-20

How to Cite

Guli I. Boltaeva, Malokhat F. Yakhshieva, & Manzura K. Uzoqova. (2025). ASSESSMENT OF RISK FACTORS AND EARLY DIAGNOSIS OF ENDOMETRIAL HYPERPLASIA IN PERIMENOPAUSAL WOMEN. World Bulletin of Public Health, 44, 61-62. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/5092

Issue

Section

Articles